2.80 USD
▲+0.09+3.32%
盘后 2.89 0.00%
2026-09-16
市值
$1.89M
市盈率
—
EPS
-40.40
股息率
—
52 周区间
2.59 – 70.80
成交量
23.98K
Beta
0.56
目标价
—
52W 低 2.5952W 高 70.80
价格走势
公司简介
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design α-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting ...